Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ROIV is expected to report earnings to fall 10.09% to -29 cents per share on November 17
Q3'25
Est.
$-0.30
Q2'25
Missed
by $0.08
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.48
Q3'24
Missed
by $0.02
The last earnings report on August 11 showed earnings per share of -33 cents, missing the estimate of -25 cents. With 559.53K shares outstanding, the current market capitalization sits at 8.02B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ROIV showed earnings on August 11, 2025. You can read more about the earnings report here.